project id: TCGA-SKCM; case submitter id: TCGA-WE-A8K5; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 7.3; age at index: 65; days to birth: -23837; days to death: 1860; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; age at diagnosis: 23837; ajcc pathologic m: M1c; ajcc pathologic n: N3; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1654.0; icd 10 code: C49.20; last known disease status: not reported; morphology: 8742/3; primary diagnosis: Lentigo maligna melanoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: Not Reported; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1562; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-WE-A8K5-06A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;